Literature DB >> 3047716

Rudolf Virchow and modern aspects of tumor pathology.

H David1.   

Abstract

Rudolf Virchow (1821-1902), the great German pathologist of the 19th century, founder of the "Zellularpathologie", also dealt with principal problems of tumor pathology. His theoretical concepts concern the definition and characterization of the tumor process, the dignity and diagnosis, published especially in his 3 monographs "Die Entwicklungsgeschichte des Krebses" (1847), "Handbuch der speciellen Pathologie und Therapie" (1854) and "Die krankhaften Geschwülste" (1863-65). The achievements of Rudolf Virchow are not related to the description and diagnosis of specific tumors together with their genesis and interpretation. There have been quite a few errors and false concepts which can longer be accepted today. The timeless modernity and topicality of Rudolf Virchow's postulations on tumor pathology is based on his general conclusions which as key propositions have retained general validity throughout more than a century. They have been confirmed and further interpreted by knowledge which has been accumulated largely over the past one or two decades in the fields of tumor research, electron microscopy, molecular biology, genetics, and immunology.

Entities:  

Mesh:

Year:  1988        PMID: 3047716     DOI: 10.1016/S0344-0338(88)80138-9

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  20 in total

1.  [Aberrant reparative tissue remodeling: histopathology and molecular pathology].

Authors:  D Jonigk
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

2.  Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer.

Authors:  Soizic Garaud; Laurence Buisseret; Cinzia Solinas; Chunyan Gu-Trantien; Alexandre de Wind; Gert Van den Eynden; Celine Naveaux; Jean-Nicolas Lodewyckx; Anaïs Boisson; Hughes Duvillier; Ligia Craciun; Lieveke Ameye; Isabelle Veys; Marianne Paesmans; Denis Larsimont; Martine Piccart-Gebhart; Karen Willard-Gallo
Journal:  JCI Insight       Date:  2019-08-13

Review 3.  [Digital pathology in immuno-oncology-current opportunities and challenges : Overview of the analysis of immune cell infiltrates using whole slide imaging].

Authors:  N Grabe; W Roth; S Foersch
Journal:  Pathologe       Date:  2018-11       Impact factor: 1.011

4.  re: Reflections on screening mammography and the early detection of breast cancer.

Authors:  M Baum
Journal:  Curr Oncol       Date:  2014-10       Impact factor: 3.677

5.  G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer.

Authors:  Junya Fujimoto; Humam Kadara; Melinda M Garcia; Mohamed Kabbout; Carmen Behrens; Diane D Liu; J Jack Lee; Luisa M Solis; Edward S Kim; Neda Kalhor; Cesar Moran; Amir Sharafkhaneh; Reuben Lotan; Ignacio I Wistuba
Journal:  J Thorac Oncol       Date:  2012-12       Impact factor: 15.609

6.  Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research.

Authors:  Antonello Punturieri; Eva Szabo; Thomas L Croxton; Steven D Shapiro; Steven M Dubinett
Journal:  J Natl Cancer Inst       Date:  2009-04-07       Impact factor: 13.506

Review 7.  Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.

Authors:  Antara Biswas; Subhajyoti De
Journal:  Am J Physiol Cell Physiol       Date:  2021-03-03       Impact factor: 4.249

8.  Novel stromal biomarkers in human breast cancer tissues provide evidence for the more malignant phenotype of estrogen receptor-negative tumors.

Authors:  Zahraa I Khamis; Ziad J Sahab; Stephen W Byers; Qing-Xiang Amy Sang
Journal:  J Biomed Biotechnol       Date:  2011-10-03

9.  Smokers with CT detected emphysema and no airway obstruction have decreased plasma levels of EGF, IL-15, IL-8 and IL-1ra.

Authors:  Juan P de-Torres; David Blanco; Ana B Alcaide; Luis M Seijo; Gorka Bastarrika; María José Pajares; Arrate Muñoz-Barrutia; Carlos Ortiz-de-Solorzano; Ruben Pio; Arantza Campo; Usua Montes; Victor Segura; Jesús Pueyo; Luis M Montuenga; Javier J Zulueta
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

10.  Embryonic mammary signature subsets are activated in Brca1-/- and basal-like breast cancers.

Authors:  Marketa Zvelebil; Erik Oliemuller; Qiong Gao; Olivia Wansbury; Alan Mackay; Howard Kendrick; Matthew J Smalley; Jorge S Reis-Filho; Beatrice A Howard
Journal:  Breast Cancer Res       Date:  2013-03-18       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.